Insulet Corp. buy BiotechBee
Start price
08.09.24
/
70%
€196.45
Target price
31.03.27
€230.00
Performance (%)
29.75%
End price
14.12.24
€254.90
Summary
This prediction ended on 14.12.24 with a price of €254.90. The BUY prediction by BiotechBee finished with a performance of 29.75%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insulet Corp. | -0.989% | -0.989% | -41.282% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % |
According to BiotechBee what are the pros and cons of Insulet Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Insulet Corp. diskutieren
Buy mit Kursziel 230,0